FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809934731> ?p ?o ?g. }

• W2809934731 abstract "To determine the rate of optimal cytoreduction in patients with advanced ovarian cancer who received neoadjuvant chemotherapy with dose-dense carboplatin and paclitaxel followed by interval debulking surgery (IDS).A retrospective study of a series of cases of Peruvian women treated with neoadjuvant chemotherapy with carboplatin (6 AUC mg/mL/min) and paclitaxel (80 mg/m2 weekly) followed by IDS, at the National Institute of Neoplastic Diseases during the 2010-2014 period.The 41 patients who made it to the interval surgery had a median age of 59 years (range: 47-73 years). In 37 (90.2%) patients, high-grade serous adenocarcinoma histology was reported. Thirty-four (82.9%) achieved optimal cytoreduction and five (14.7%), a complete pathological response. Progression-free survival at one year and two years was 74.7% and 51.8%, respectively. Overall survival at one year and two years was 85.2% and 71.4%, respectively. The risk of progression and death was greater in patients without optimal cytoreduction and in patients with postsurgery levels of carcinoembryonic antigen 125 > 30 U/mL.Neoadjuvant therapy with dose-dense carboplatin and paclitaxel achieved an elevated frequency of optimal cytoreduction. The post-surgery levels of carcinoembryonic antigen 125 and optimal cytoreduction were independent factors of progression-free survival and overall survival.Determinar la tasa de citorreducción óptima en pacientes con cáncer de ovario avanzado que recibieron quimioterapia neoadyuvante con carboplatino y paclitaxel dosis densa seguido de cirugía de citorreducción de intervalo (CCI).Estudio de una serie de casos retrospectiva de mujeres peruanas tratadas con quimioterapia neoadyuvante con carboplatino (AUC 6 mg/ml/min) y paclitaxel (80 mg/m2 semanal) seguido de CCI, en el Instituto Nacional de Enfermedades Neoplásicas durante el período 2010-2014.Los 41 pacientes que alcanzaron cirugía de intervalo, tuvieron una mediana de edad de 59 años (rango: 47-73 años). En 37 (90,2%) pacientes se reportó histología de adenocarcinoma seroso de alto grado. Treinta y cuatro (82,9%) lograron citorreducción óptima y cinco (14,7%) respuesta patológica completa. La sobrevida libre de progresión al año y 2 años fueron 74,7% y 51,8%, respectivamente. La sobrevida global al año y 2 años fue 85,2% y 71,4%, respectivamente. El riesgo de progresión y muerte fue mayor en pacientes sin citorreducción óptima y pacientes con niveles de dosaje del antígeno carcinoembrionario 125 postoperatorio > 30 U/ml.La neoadyuvancia con carboplatino y paclitaxel dosis densa logró una frecuencia elevada de citorreducción óptima. Los niveles de antígeno carcinoembrionario 125 postoperatorios y citorreducción óptima resultaron factores independientes de sobrevida libre de progresión y sobrevida global." @default.
• W2809934731 created "2018-07-10" @default.
• W2809934731 creator A5016406587 @default.
• W2809934731 creator A5029356961 @default.
• W2809934731 creator A5048286851 @default.
• W2809934731 creator A5072128030 @default.
• W2809934731 creator A5079381386 @default.
• W2809934731 creator A5081145572 @default.
• W2809934731 creator A5082959086 @default.
• W2809934731 creator A5086970175 @default.
• W2809934731 creator A5091899736 @default.
• W2809934731 date "2018-04-05" @default.
• W2809934731 modified "2023-09-23" @default.
• W2809934731 title "Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el Instituto Nacional de Enfermedades Neoplásicas del Perú" @default.
• W2809934731 doi "https://doi.org/10.17843/rpmesp.2018.351.3599" @default.
• W2809934731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29924276" @default.
• W2809934731 hasPublicationYear "2018" @default.
• W2809934731 type Work @default.
• W2809934731 sameAs 2809934731 @default.
• W2809934731 citedByCount "2" @default.
• W2809934731 countsByYear W28099347312020 @default.
• W2809934731 crossrefType "journal-article" @default.
• W2809934731 hasAuthorship W2809934731A5016406587 @default.
• W2809934731 hasAuthorship W2809934731A5029356961 @default.
• W2809934731 hasAuthorship W2809934731A5048286851 @default.
• W2809934731 hasAuthorship W2809934731A5072128030 @default.
• W2809934731 hasAuthorship W2809934731A5079381386 @default.
• W2809934731 hasAuthorship W2809934731A5081145572 @default.
• W2809934731 hasAuthorship W2809934731A5082959086 @default.
• W2809934731 hasAuthorship W2809934731A5086970175 @default.
• W2809934731 hasAuthorship W2809934731A5091899736 @default.
• W2809934731 hasBestOaLocation W28099347311 @default.
• W2809934731 hasConcept C121608353 @default.
• W2809934731 hasConcept C126322002 @default.
• W2809934731 hasConcept C126894567 @default.
• W2809934731 hasConcept C141071460 @default.
• W2809934731 hasConcept C2776694085 @default.
• W2809934731 hasConcept C2777292972 @default.
• W2809934731 hasConcept C2777387746 @default.
• W2809934731 hasConcept C2778239845 @default.
• W2809934731 hasConcept C2780427987 @default.
• W2809934731 hasConcept C2781100745 @default.
• W2809934731 hasConcept C2781451048 @default.
• W2809934731 hasConcept C29456083 @default.
• W2809934731 hasConcept C71924100 @default.
• W2809934731 hasConceptScore W2809934731C121608353 @default.
• W2809934731 hasConceptScore W2809934731C126322002 @default.
• W2809934731 hasConceptScore W2809934731C126894567 @default.
• W2809934731 hasConceptScore W2809934731C141071460 @default.
• W2809934731 hasConceptScore W2809934731C2776694085 @default.
• W2809934731 hasConceptScore W2809934731C2777292972 @default.
• W2809934731 hasConceptScore W2809934731C2777387746 @default.
• W2809934731 hasConceptScore W2809934731C2778239845 @default.
• W2809934731 hasConceptScore W2809934731C2780427987 @default.
• W2809934731 hasConceptScore W2809934731C2781100745 @default.
• W2809934731 hasConceptScore W2809934731C2781451048 @default.
• W2809934731 hasConceptScore W2809934731C29456083 @default.
• W2809934731 hasConceptScore W2809934731C71924100 @default.
• W2809934731 hasLocation W28099347311 @default.
• W2809934731 hasLocation W28099347312 @default.
• W2809934731 hasLocation W28099347313 @default.
• W2809934731 hasOpenAccess W2809934731 @default.
• W2809934731 hasPrimaryLocation W28099347311 @default.
• W2809934731 hasRelatedWork W1567229547 @default.
• W2809934731 hasRelatedWork W1968900823 @default.
• W2809934731 hasRelatedWork W2014690672 @default.
• W2809934731 hasRelatedWork W2072767112 @default.
• W2809934731 hasRelatedWork W2311734504 @default.
• W2809934731 hasRelatedWork W2321468987 @default.
• W2809934731 hasRelatedWork W2330726202 @default.
• W2809934731 hasRelatedWork W2443311901 @default.
• W2809934731 hasRelatedWork W2753631187 @default.
• W2809934731 hasRelatedWork W59268075 @default.
• W2809934731 isParatext "false" @default.
• W2809934731 isRetracted "false" @default.
• W2809934731 magId "2809934731" @default.
• W2809934731 workType "article" @default.